Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-15 of 15

Sort by

Sort Order Select

Journal Articles

miR-9 and miR-200 Regulate PDGFRβ-Mediated Endothelial Differentiation of Tumor Cells in Triple-Negative Breast Cancer

Elvira D'Ippolito, Ilaria Plantamura, Lucia Bongiovanni, Patrizia Casalini, Sara Baroni, Claudia Piovan, Rosaria Orlandi, Ambra V. Gualeni, Annunziata Gloghini, Anna Rossini, Sara Cresta, Anna Tessari, Filippo De Braud, Gianpiero Di Leva, Claudio Tripodo, Marilena V. Iorio

Cancer Res (2016) 76 (18): 5562–5572.

https://doi.org/10.1158/0008-5472.CAN-16-0140

Published: 15 September 2016

View articletitled, miR-9 and miR-200 Regulate PDGFRβ-Mediated Endothelial Differentiation of Tumor Cells in Triple-Negative Breast Cancer

Includes: Supplementary data

Journal Articles

Abstract 1068: The promise of miR-205 in HER2+ breast cancer: predicting response to Trastuzumab and overcoming resistance

Claudia Piovan, Elvira D’Ippolito, Ilaria Plantamura, Patrizia Casalini, Elda Tagliabue, Marilena V. Iorio

Cancer Res (2016) 76 (14_Supplement): 1068.

https://doi.org/10.1158/1538-7445.AM2016-1068

Published: 15 July 2016

View articletitled, Abstract 1068: The promise of miR-205 in HER2+ breast cancer: predicting response to Trastuzumab and overcoming resistance

Journal Articles

Abstract A18: miR-9 and miR-200 regulate PDGFRβ-mediated endothelial differentiation of neoplastic cells in triple-negative breast cancer

Elvira D'Ippolito, Ilaria Plantamura, Lucia Bongiovanni, Patrizia Casalini, Sara Baroni, Claudia Piovan, Rosaria Orlandi, Ambra V. Gualeni, Annunziata Gloghini, Anna Rossini, Filippo De Braud, Elda Tagliabue, Claudio Tripodo, Marilena V. Iorio

Cancer Res (2016) 76 (6_Supplement): A18.

https://doi.org/10.1158/1538-7445.NONRNA15-A18

Published: 13 May 2016

View articletitled, Abstract A18: miR-9 and miR-200 regulate PDGFRβ-mediated endothelial differentiation of neoplastic cells in triple-negative breast cancer

Journal Articles

Abstract 1395: Conversion to stem cell state in response to microenvironmental cues is regulated by balance between epithelial and mesenchymal features in lung cancer

Francesca Andriani, Giulia Bertolini, Federica Facchinetti, Erika Baldoli, Massimo Moro, Patrizia Casalini, Roberto Caserini, Ugo Pastorino, Gabriella Sozzi, Luca Roz

Cancer Res (2015) 75 (15_Supplement): 1395.

https://doi.org/10.1158/1538-7445.AM2015-1395

Published: 01 August 2015

View articletitled, Abstract 1395: Conversion to stem cell state in response to microenvironmental cues is regulated by balance between epithelial and mesenchymal features in lung cancer

Journal Articles

Abstract 5207: miR-491 and miR-218: Two possible tools to reduce FOXP3 expression in breast carcinomas

Martina D. Modica, Tiziana Triulzi, Viola Regondi, Marilena V. Iorio, Andrea Balsari, Elda Tagliabue, Patrizia Casalini

Cancer Res (2014) 74 (19_Supplement): 5207.

https://doi.org/10.1158/1538-7445.AM2014-5207

Published: 01 October 2014

View articletitled, Abstract 5207: miR-491 and miR-218: Two possible tools to reduce FOXP3 expression in breast carcinomas

Journal Articles

Abstract 4381: MiR-205 and Trastuzumab: Potential as adjuvant therapeutic tool and predictive biomarker

Elvira D'Ippolito, Claudia Piovan, Ilaria Plantamura, Marta Giussani, Patrizia Casalini, Manuela Campiglio, Elda Tagliabue, Marilena V. Iorio

Cancer Res (2014) 74 (19_Supplement): 4381.

https://doi.org/10.1158/1538-7445.AM2014-4381

Published: 01 October 2014

View articletitled, Abstract 4381: MiR-205 and Trastuzumab: Potential as adjuvant therapeutic tool and predictive biomarker

Journal Articles

Abstract 4269: Opposite effect of ECM features in breast carcinoma progression according to tumor cell differentiation

Tiziana Triulzi, Marco Sandri, Patrizia Casalini, Piera Aiello, Andrea Balsari, Rosaria Orlandi, Elda Tagliabue

Cancer Res (2012) 72 (8_Supplement): 4269.

https://doi.org/10.1158/1538-7445.AM2012-4269

Published: 15 April 2012

View articletitled, Abstract 4269: Opposite effect of ECM features in breast carcinoma progression according to tumor cell differentiation

Journal Articles

Abstract 2089: MiR-205 role in triple negative breast cancer

Marilena V. Iorio, Claudia Piovan, Gianpiero Di Leva, Patrizia Casalini, Monica Tortoreto, Ilaria Plantamura, Cristian Taccioli, Carlo M. Croce, Elda Tagliabue

Cancer Res (2010) 70 (8_Supplement): 2089.

https://doi.org/10.1158/1538-7445.AM10-2089

Published: 15 April 2010

View articletitled, Abstract 2089: MiR-205 role in triple negative breast cancer

Journal Articles

Abstract #1392: miR-205: A new tumor suppressor in breast cancer

Marilena Iorio, Claudia Piovan, Patrizia Casalini, Gianpiero Di Leva, Andrea Merlo, Tiziana Triulzi, Sylvie Ménard, Carlo Croce, Elda Tagliabue

Cancer Res (2009) 69 (9_Supplement): 1392.

Published: 01 May 2009

View articletitled, Abstract #1392: miR-205: A new tumor suppressor in breast cancer

Journal Articles

microRNA-205 Regulates HER3 in Human Breast Cancer

Marilena V. Iorio, Patrizia Casalini, Claudia Piovan, Gianpiero Di Leva, Andrea Merlo, Tiziana Triulzi, Sylvie Ménard, Carlo M. Croce, Elda Tagliabue

Cancer Res (2009) 69 (6): 2195–2200.

https://doi.org/10.1158/0008-5472.CAN-08-2920

Published: 17 March 2009

View articletitled, microRNA-205 Regulates HER3 in Human Breast Cancer

Includes: Supplementary data

Journal Articles

Involvement of miR-205 in human breast cancer

Marilena Iorio, Gianpiero Di Leva, Patrizia Casalini, Claudia Piovan, Rosaria Orlandi, Tiziana Triulzi, Elda Tagliabue, Carlo Croce, Sylvie Menard

Cancer Res (2008) 68 (9_Supplement): 5045.

Published: 01 May 2008

View articletitled, Involvement of miR-205 in human breast cancer

Journal Articles

MicroRNA Signatures in Human Ovarian Cancer

Marilena V. Iorio, Rosa Visone, Gianpiero Di Leva, Valentina Donati, Fabio Petrocca, Patrizia Casalini, Cristian Taccioli, Stefano Volinia, Chang-Gong Liu, Hansjuerg Alder, George A. Calin, Sylvie Ménard, Carlo M. Croce

Cancer Res (2007) 67 (18): 8699–8707.

https://doi.org/10.1158/0008-5472.CAN-07-1936

Published: 17 September 2007

View articletitled, MicroRNA Signatures in Human Ovarian Cancer

Includes: Supplementary data

Journal Articles

Decrease aggressiveness of HER2-positive breast carcinomas with current therapies

Sylvie Menard, Elda Tagliabue, Roberto Agresti, Patrizia Casalini, Serenella Pupa, Manuela Campiglio, Andrea Balsari

Cancer Res (2005) 65 (9_Supplement): 512.

Published: 01 May 2005

View articletitled, Decrease aggressiveness of HER2-positive breast carcinomas with current therapies

Journal Articles

SEL1L Expression Decreases Breast Tumor Cell Aggressiveness in Vivo and in Vitro

Rosaria Orlandi, Monica Cattaneo, Flavia Troglio, Patrizia Casalini, Chiara Ronchini, Sylvie Ménard, Ida Biunno

Cancer Res (2002) 62 (2): 567–574.

Published: 01 January 2002

View articletitled, SEL1L Expression Decreases Breast Tumor Cell Aggressiveness in Vivo and in Vitro

Journal Articles

Chimeric Murine-Human Antibodies Directed against Folate Binding Receptor Are Efficient Mediators of Ovarian Carcinoma Cell Killing

Leslie R. Coney, Delia Mezzanzanica, David Sanborn, Patrizia Casalini, Maria I. Colnaghi, Vincent R. Zurawski, Jr.

Cancer Res (1994) 54 (9): 2448–2455.

Published: 01 May 1994

View articletitled, Chimeric Murine-Human Antibodies Directed against Folate Binding Receptor Are Efficient Mediators of Ovarian Carcinoma Cell Killing

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

miR-9 and miR-200 Regulate PDGFRβ-Mediated Endothelial Differentiation of Tumor Cells in Triple-Negative Breast Cancer

Abstract 1068: The promise of miR-205 in HER2+ breast cancer: predicting response to Trastuzumab and overcoming resistance

Abstract A18: miR-9 and miR-200 regulate PDGFRβ-mediated endothelial differentiation of neoplastic cells in triple-negative breast cancer

Abstract 1395: Conversion to stem cell state in response to microenvironmental cues is regulated by balance between epithelial and mesenchymal features in lung cancer

Abstract 5207: miR-491 and miR-218: Two possible tools to reduce FOXP3 expression in breast carcinomas

Abstract 4381: MiR-205 and Trastuzumab: Potential as adjuvant therapeutic tool and predictive biomarker

Abstract 4269: Opposite effect of ECM features in breast carcinoma progression according to tumor cell differentiation

Abstract 2089: MiR-205 role in triple negative breast cancer

Abstract #1392: miR-205: A new tumor suppressor in breast cancer

microRNA-205 Regulates HER3 in Human Breast Cancer

Involvement of miR-205 in human breast cancer

MicroRNA Signatures in Human Ovarian Cancer

Decrease aggressiveness of HER2-positive breast carcinomas with current therapies

SEL1L Expression Decreases Breast Tumor Cell Aggressiveness in Vivo and in Vitro

Chimeric Murine-Human Antibodies Directed against Folate Binding Receptor Are Efficient Mediators of Ovarian Carcinoma Cell Killing

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only